TABLE 1.
No. of patients | % | |
---|---|---|
D’Amico risk | ||
Low | 857 | 45.7 |
Intermediate | 703 | 37.5 |
High | 316 | 16.8 |
Biopsy Gleason score | ||
2–6 | 1151 | 61.3 |
7 | 563 | 30.0 |
8–10 | 163 | 8.7 |
Prostate-specific antigen (ng/mL) | ||
≤4 | 310 | 16.5 |
4.1–10 | 1263 | 67.3 |
10.1–20 | 239 | 12.7 |
>20 | 65 | 3.5 |
Clinical stage (1992 TNM) | ||
T1a/b | 16 | 0.9 |
T1c | 1035 | 55.1 |
T2a | 495 | 26.4 |
T2b | 201 | 10.7 |
T2c | 119 | 6.3 |
T3a | 11 | 0.6 |